Healthy | Non-severe | Severe | p-value | |
---|---|---|---|---|
n | 49 | 42 | 54 | - |
Age (years) | 50.6±8.3 | 54.1±17.8 | 58.3±15.3 | 0.26 |
Sex (% female) | 100% | 100% | 100% | NA |
Duration from onset (years) | - | 8.1±10.4a | 12.4±13.8b | 0.22 |
Duration from diagnosis (years) | - | 5.7±7.4c | 8.7±7.7d | 0.092 |
BMI | - | 25.7±4.3e | 25.5±5.5f | 0.59 |
Stimulated salivary flow rate | - | 7.0±3.3 ml/5 min | 1.8±0.8 ml/5 min | < 2.2 × 10-16 |
Schirmer right (mm/5 min) | - | 8.1±10.5g | 6.3±9.0d | 0.49 |
Schirmer left (mm/5 min) | - | 9.4±11.3g | 6.9±9.6d | 0.36 |
Anti-SSA | - | 27/73.0%h | 35/74.5%i | 0.88 |
Anti-SSB | - | 8/21.6%h | 14/29.8%i | 0.40 |
Seropositive (SSA and/or SSB) | - | 27/73.0%h | 35/74.5%i | 0.88 |
cDMARD | - | 11/32.4%e | 10/24.4%j | 0.21 |
bDMARD (anti-TNF) | - | 0k | 0k | NA |
Glucocorticoid | - | 4/11.8%e | 2/5.0%l | 0.30 |
Cyclosporine eye drops | - | 6/27.3%m | 725.9%n | 0.93 |
Oral pilocarpine | - | 3/14.3%o | 4/16%p | 0.89 |
Natural tears | - | 6/25%q | 10/38.5%r | 0.32 |
Angina pectoris | - | 1r | 0l | 0.23 |
Autoimmune gastritis | - | 0r | 1s | 0.43 |
Autoimmune thyroid disease | - | 1j | 4t | 0.27 |
Proteinuria | - | 0p | 3u | 0.16 |
Hematuria | - | 0p | 1g | 0.42 |
Gynaecologic manifestation | - | 1p | 2s | 0.85 |
Non-specific interstitial pneumonia | - | 0q | 1h | 0.44 |
Fibromyalgia | - | 0q | 2s | 0.27 |
Anemia | - | 2p | 3s | 0.98 |
Leukopenia | - | 1p | 3s | 0.57 |
Neutropenia | - | 1p | 2s | 0.85 |
Thrombocytopenia | - | 0p | 1s | 0.44 |
Cancer | - | 1p | 1u | 0.78 |
Sclerosing cholangitis | - | 0p | 1u | 0.44 |
Psoriasis | - | 1j | 1t | 0.88 |
Other autoimmune diseases | - | 1j | 1t | 0.88 |